Aumolertinib Combined with Carbamazepine and Intrathecal Pemetrexed for EGFR-mutated LM NSCLC with Symptomatic Epilepsy

被引：0
|
作者：
Li, L. [1 ]
Yang, M. [2 ]
Huang, D. Y. [1 ]
Liu, F. [2 ]
Zhang, L. [3 ]
Song, X. W. [1 ]
Lv, Y. J. [1 ]
Teng, C. [1 ]
Fan, C. J. [1 ]
Tian, D. [1 ]
Shen, W. X. [1 ]
Jiang, Q. Y. [1 ]
Lu, D. [1 ]
Xin, T. [1 ]
机构：
[1] Harbin Med Univ, Affiliated Hosp 2, Harbin, Peoples R China
[2] China Japan Friendship Hosp, Beijing, Peoples R China
[3] Daqing Oilfield Gen Hosp, Daqing, Heilongjiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期
关键词：
Aumolertinib; Intrathecal; injection; Symptomatic epilepsy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-42
引用
收藏
页码：S351 / S351
页数：1
相关论文
共 50 条
  • [41] Osimertinib also improves overall survival in EGFR-mutated NSCLC
    Lichert, Frank
    PNEUMOLOGIE, 2024, 78 (03): : 143 - 143
  • [42] Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC
    Ramalingam, S. S.
    Vansteenkiste, J.
    Planchard, D.
    Cho, B. C.
    Gray, J. E.
    Ohe, Y.
    Zhou, C.
    Reungwetwattana, T.
    Cheng, Y.
    Chewaskulyong, B.
    Shah, R.
    Cobo, M.
    Lee, K. H.
    Cheema, P.
    Tiseo, M.
    John, T.
    Lin, M-C
    Imamura, F.
    Kurata, T.
    Todd, A.
    Hodge, R.
    Saggese, M.
    Rukazenkov, Y.
    Soria, J-C
    Boyer, Michael
    Lee, Chee
    Hughes, Brett
    O'Byrne, Kenneth
    Briggs, Peter
    Milward, Michael
    John, Thomas
    Demedts, Ingel
    Vansteenkiste, Johan
    Bustin, Frederique
    Barrios, Carlos Henrique
    Timcheva, Constanta
    Butts, Charles
    Goss, Glenwood
    Juergens, Rosalyn
    Leighl, Natasha
    Cheng, Susanna
    Burkes, Ronald
    Zhou, Caicun
    Zhang, Helong
    Shu, Yongqian
    Cheng, Ying
    Zhou, Qing
    Li, Wei
    Feng, Guosheng
    He, Yong
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (01): : 41 - 50
  • [43] A phase II trial of atezolizumab, bevacizumab, pemetrexed and carboplatin combination for metastatic EGFR-mutated NSCLC after TKI failure
    Lam, T. C.
    Tsang, K.
    Choi, H.
    Lee, V. H. F.
    Lam, K. O.
    Chiang, C. L.
    So, T. H.
    Chan, W. W.
    Nyaw, S. F.
    Lim, F.
    Lau, J. O.
    Chik, J.
    Kong, S. F.
    Lee, A. W. M.
    ANNALS OF ONCOLOGY, 2020, 31 : S1389 - S1389
  • [44] Chemotherapy in EGFR-mutated NSCLC: optimizing combinations with TKIs and amivantamab
    Rosell, Rafael
    Gonzalez-Cao, Maria
    NATURE REVIEWS CLINICAL ONCOLOGY, 2024, 21 (03) : 169 - 170
  • [45] Aumolertinib as adjuvant therapy in postoperative EGFR-mutated non-small cell lung cancer
    Zhang, Q.
    He, C.
    He, T.
    Wang, Y.
    Lv, W.
    Hu, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S73 - S73
  • [46] Continuous CR for EGFR-Mutated NSCLC with Brain Metastasis and Giant Lung Lesion Using Aumolertinib Plus Radiotherapy as First-Line Treatment
    Wu, Q.
    Li, W.
    Wang, J. T.
    Pu, D.
    Li, Y.
    Xu, F.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S664 - S664
  • [47] Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
    Silvia La Monica
    Roberta Minari
    Daniele Cretella
    Lisa Flammini
    Claudia Fumarola
    Mara Bonelli
    Andrea Cavazzoni
    Graziana Digiacomo
    Maricla Galetti
    Denise Madeddu
    Angela Falco
    Costanza Annamaria Lagrasta
    Anna Squadrilli
    Elisabetta Barocelli
    Alessandro Romanel
    Federico Quaini
    Pier Giorgio Petronini
    Marcello Tiseo
    Roberta Alfieri
    Journal of Experimental & Clinical Cancer Research, 38
  • [48] Third generation EGFR inhibitor osimertinib combined with pemetrexed or cisplatin exerts long-lasting anti-tumor effect in EGFR-mutated pre-clinical models of NSCLC
    La Monica, Silvia
    Minari, Roberta
    Cretella, Daniele
    Flammini, Lisa
    Fumarola, Claudia
    Bonelli, Mara
    Cavazzoni, Andrea
    Digiacomo, Graziana
    Galetti, Maricla
    Madeddu, Denise
    Falco, Angela
    Lagrasta, Costanza Annamaria
    Squadrilli, Anna
    Barocelli, Elisabetta
    Romanel, Alessandro
    Quaini, Federico
    Petronini, Pier Giorgio
    Tiseo, Marcello
    Alfieri, Roberta
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
  • [49] Summary of Research: Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC
    Masahiro Tsuboi
    Roy S. Herbst
    Thomas John
    Terufumi Kato
    Margarita Majem
    Christian Grohé
    Jie Wang
    Jonathan W. Goldman
    Shun Lu
    Filippo de Marinis
    Frances A. Shepherd
    Ki Hyeong Lee
    Nhieu Thi Le
    Arunee Dechaphunkul
    Dariusz Kowalski
    Laura Bonanno
    Manuel Dómine
    Lynne Poole
    Ana Bolanos
    Yuri Rukazenkov
    Yi-Long Wu
    Targeted Oncology, 2024, 19 : 131 - 134
  • [50] Simulation in the Management of EGFR-Mutated Advanced NSCLC: Seeing Beyond Age
    Carey, Christine
    Herrmann, Tara
    Warters, Martin
    Blevins, Douglas
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : S270 - S270
12345